79181306 - PLEXPRIME

Information

• Trademark
• 79181306

• Source

• Serial Number

  79181306

• Registration Number

  5215648

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth

• Filing Date

  September 17, 2015
  9 years ago

• Registration Date

  June 06, 2017
  7 years ago

• Transaction Date

  February 14, 2024
  10 months ago

• Status Date

  February 13, 2024
  10 months ago

• Published for Opposition Date

  March 21, 2017
  7 years ago

• Location Date

  February 13, 2024
  10 months ago

• Status Code

  739

• Current Location

  GENERIC WEB UPDATE

  Employee Name

  LAW, CHRISTOPHER M

• Attorney Docket Number

  120776SPX002

  Attorney Name

  Mainak H. Mehta

  Law Office Assigned Location Code

  L30

• Owners

  • SpeeDx Pty Ltd

Case File Statements

• GS0051: Pharmaceutical and veterinary preparations and substances for the diagnosis of diseases or detection or identification of pathogens for medical and veterinary purposes; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens; enzymes for pharmaceutical, veterinary and medical purposes; medical kits in this class consisting of catalytic DNA molecules and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; diagnostic reagents for medical or veterinary use; biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders
• PM0001: PLEX PRIME
• GS0011: Chemicals used in industry, science, photography; chemicals used in agriculture, horticulture and forestry except fungicides, herbicides, insecticides, and parasiticides; chemical reagents and reactants in this class for non-medical purposes; enzymes for industrial purposes, namely, for use in the biotechnology industry; nucleic acid sequences, other than medical and veterinary purposes; nucleic recombinant acids; acids, namely, inorganic acids; organic acids for use in the biotechnology industry; DNA polymerase, other than medical and veterinary purposes; chemicals used in food processing and screening; chemicals used in environmental monitoring
• GS0101: Surgical, medical and veterinary apparatus and instruments, namely, surgical apparatus and instruments for medical or veterinary use; diagnostic testing apparatus and instruments for medical purposes, namely, for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; point of care medical devices for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; medical screening apparatus in this class for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy

Case File Event Statements

• 2/13/2024 - 10 months ago

  41 - NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED Type: NA75

• 2/13/2024 - 10 months ago

  40 - REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. Type: C75A

• 2/12/2024 - 10 months ago

  39 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 6/6/2023 - a year ago

  38 - TEAS SECTION 71 & 15 RECEIVED Type: ES75

• 6/6/2022 - 2 years ago

  37 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3

• 10/28/2017 - 7 years ago

  36 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 9/14/2017 - 7 years ago

  35 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 9/14/2017 - 7 years ago

  34 - FINAL DISPOSITION PROCESSED Type: FIMP

• 9/6/2017 - 7 years ago

  33 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 6/6/2017 - 7 years ago

  32 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 3/21/2017 - 7 years ago

  31 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 3/21/2017 - 7 years ago

  30 - PUBLISHED FOR OPPOSITION Type: PUBO

• 3/17/2017 - 7 years ago

  29 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 3/10/2017 - 7 years ago

  28 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 3/1/2017 - 7 years ago

  27 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 3/1/2017 - 7 years ago

  26 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 3/1/2017 - 7 years ago

  25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 2/13/2017 - 7 years ago

  24 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 2/10/2017 - 7 years ago

  23 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 2/1/2017 - 7 years ago

  22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 2/1/2017 - 7 years ago

  21 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 2/1/2017 - 7 years ago

  20 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 2/1/2017 - 7 years ago

  19 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 2/1/2017 - 7 years ago

  18 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 12/16/2016 - 8 years ago

  17 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 9/1/2016 - 8 years ago

  16 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 9/1/2016 - 8 years ago

  15 - FINAL REFUSAL E-MAILED Type: GNFR

• 9/1/2016 - 8 years ago

  14 - FINAL REFUSAL WRITTEN Type: CNFR

• 8/16/2016 - 8 years ago

  13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/16/2016 - 8 years ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/16/2016 - 8 years ago

  11 - ASSIGNED TO LIE Type: ALIE

• 8/10/2016 - 8 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 2/27/2016 - 8 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 2/10/2016 - 8 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 2/10/2016 - 8 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 2/10/2016 - 8 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 2/9/2016 - 8 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/9/2016 - 8 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 2/3/2016 - 8 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 2/3/2016 - 8 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 1/30/2016 - 8 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR